The FDA resolved the semaglutide shortage in late 2024 and the tirzepatide shortage in early 2025, which narrowed the compounding window but did not eliminate all legitimate activity
Surgical options when you want a more definitive change If the concern is moderate to significant fat, loose skin, or both, surgery may be the most predictable route
Compare to the previous week to identify trends
Moreover, studies are limited at this time, and the medication hasnt been tested at all on humans during pregnancy
But I do think its a good one to consider including as a prokinetic, because we at least know that it helps with stomach emptying, and it may help with small intestine transit as well
Winocour, J., Gupta, V., Ramirez, J